@misc{10818/54600,
year = {2023},
url = {http://hdl.handle.net/10818/54600},
abstract = {Fungal infections have become a common threat in Intensive Care Units (ICU). The epidemiology of invasive fungal diseases (IFD) has been extensively studied in patients severely immunosuppressed over the last 20–30 years, however, the type of patients that have been admitted to hospitals in the last decade has made the healthcare system and ICU a different setting with more vulnerable hosts. Patients admitted to an ICU tend to have older age and higher severity of disease. Moreover, the number of patients being treated in ICU are often immunosuppressed as a result of the widespread use of immunomodulatory agents, such as corticosteroids, chemotherapy, and biological agents. The development of Invasive Pulmonary aspergillosis (IPA) reflects a different clinical trajectory to affected patients. The increasing use of corticosteroids would probably explain the higher incidence of IPA especially in critically ill patients. In refractory septic shock, severe community-acquired pneumonia (SCAP), and acute respiratory distress syndrome (ARDS), the use of corticosteroids has re-emerged in order to decrease unacceptably high mortality rates associated with these clinical conditions. It is also pertinent to note that different reports have used different diagnosis criteria, and this might explain the different incidence rates. Another layer of complexity to better understand current IPA data is related to more aggressive acquisition of samples through invasive respiratory examinations.},
publisher = {Diagnostics},
title = {Invasive Pulmonary Aspergillosis: Not Only a Disease Affecting Immunosuppressed Patients},
doi = {10.3390/diagnostics13030440},
author = {Zaragoza, Rafael and Sole-Violan, Jordi and Cusack, Rachel and Rodriguez, Alejandro and Reyes, Luis Felipe and Martin Loeches, Ignacio},
}